Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today announced the launch of a generic version of Letairis®1 (ambrisentan) Tablets, 5 mg ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE